{"id":1110,"date":"2020-09-03T18:08:00","date_gmt":"2020-09-03T16:08:00","guid":{"rendered":"https:\/\/euroconsum.eu\/?p=1110"},"modified":"2023-04-09T08:03:10","modified_gmt":"2023-04-09T06:03:10","slug":"archiv-alternative-krebstherapien-immer-ein-risiko","status":"publish","type":"post","link":"https:\/\/euroconsum.eu\/sk\/2020\/09\/03\/archiv-alternative-krebstherapien-immer-ein-risiko\/","title":{"rendered":"Alternat\u00edvne terapie rakoviny - v\u017edy riziko"},"content":{"rendered":"<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"720\" height=\"480\" src=\"https:\/\/euroconsum.eu\/wp-content\/uploads\/2022\/03\/Bild_2022-03-11_235720.png\" alt=\"\" class=\"wp-image-1648\"\/><figcaption>Obr\u00e1zok: marijana1\/Pixabay (licencia CCO)<\/figcaption><\/figure>\n\n\n\n<p>Diagn\u00f3za rakoviny je v\u017edy udalos\u0165ou, ktor\u00e1 men\u00ed \u017eivot. Okrem v\u0161etk\u00e9ho ostatn\u00e9ho vyvol\u00e1va aj ve\u013ea pochybnost\u00ed a neistoty, pokia\u013e ide o mo\u017enosti lie\u010dby. \u013dudia sa nie v\u017edy riadia radami onkologick\u00fdch odborn\u00edkov, ale uchy\u013euj\u00fa sa k tzv. alternat\u00edvnej medic\u00edne.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Odborn\u00edci pred t\u00fdm v\u017edy varovali. Teraz s\u00fa k dispoz\u00edcii aj dobre podlo\u017een\u00e9 v\u00fdsledky v ot\u00e1zke, ako s\u00fa na tom pacienti, ktor\u00ed sa lie\u010dili len pod\u013ea vedeck\u00fdch met\u00f3d, v porovnan\u00ed s t\u00fdmi, ktor\u00ed sa spoliehali v\u00fdlu\u010dne na \"alternat\u00edvnu medic\u00ednu\". V roku 2017 publikovali vedci z Yaleovej univerzity v USA vysoko cenen\u00fa \u0161t\u00fadiu na t\u00fato t\u00e9mu.<sup><a href=\"https:\/\/euroconsum.eu\/sk\/publication\/alternative-krebstherapien-immer-risiko\/#fn:1\">1<\/a><\/sup>&nbsp;vykonan\u00e9.<\/p>\n\n\n\n<p>Na z\u00e1klade registra rakoviny v USA boli zostaven\u00e9 dve porovn\u00e1vacie skupiny konven\u010dne a vedecky lie\u010den\u00fdch pacientov. Pacienti mali naj\u010dastej\u0161ie typy rakoviny (rakovina prsn\u00edka, prostaty, p\u013e\u00fac alebo hrub\u00e9ho \u010dreva), ale e\u0161te nemali metast\u00e1zy. V priebehu siedmich rokov sa porovn\u00e1vala miera pre\u017eitia t\u00fdchto dvoch skup\u00edn.<\/p>\n\n\n\n<p>V\u00fdsledok je jasn\u00fd: v ka\u017edom \u010dasovom okamihu je po\u010det \u00famrt\u00ed pri alternat\u00edvnej lie\u010dbe pribli\u017ene dvakr\u00e1t vy\u0161\u0161\u00ed ako u konven\u010dne lie\u010den\u00fdch \u013eud\u00ed. Po siedmich rokoch zomrela pri alternat\u00edvnej lie\u010dbe pribli\u017ene polovica pacientov a pri konven\u010dnej lie\u010dbe len dobr\u00e1 \u0161tvrtina. V z\u00e1vislosti od typu rakoviny bol rozdiel e\u0161te v\u00fdraznej\u0161\u00ed. A tento trend bude skuto\u010dne pokra\u010dova\u0165 - z \u010disto \u0161tatistick\u00e9ho h\u013eadiska a\u017e do bodu, ke\u010f v\u0161etci alternat\u00edvne lie\u010den\u00ed pacienti zomreli a pribli\u017ene polovica vedecky lie\u010den\u00fdch pacientov st\u00e1le \u017eije.<\/p>\n\n\n\n<p>Ide predov\u0161etk\u00fdm o \u00favahu, ktor\u00e1 jasne odde\u013euje \"len vedeck\u00fa\" a \"len alternat\u00edvnu\" lie\u010dbu. Samozrejme, je zauj\u00edmav\u00e9 zisti\u0165, \u010di tak\u00e9to \u00fa\u010dinky m\u00e1 aj \"komplement\u00e1rna\" lie\u010dba, t. j. tak\u00e1, ktor\u00e1 kombinuje vedeck\u00e9 a alternat\u00edvne medic\u00ednske pr\u00edstupy.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<p>T\u00edm Yale to sledoval v&nbsp;<strong>N\u00e1sledn\u00e1 \u0161t\u00fadia<\/strong><sup><a href=\"https:\/\/euroconsum.eu\/sk\/publication\/alternative-krebstherapien-immer-risiko\/#fn:2\">2<\/a><\/sup>&nbsp;Uk\u00e1zalo sa, \u017ee aj v tejto kon\u0161tel\u00e1cii sa u pacientov, ktor\u00ed dost\u00e1vali doplnkov\u00fa lie\u010dbu, jasne prejavili nev\u00fdhody. V\u00fdskumn\u00edci to pripisuj\u00fa skuto\u010dnosti, \u017ee v tejto skupine neboli pri konven\u010dnej lie\u010dbe zriedkav\u00e9 oneskorenia a odmietnutia terapie. To poukazuje na tendenciu pacientov, ktor\u00ed \"len\" absolvuj\u00fa lie\u010dbu komplement\u00e1rnou alternat\u00edvnou medic\u00ednou, ma\u0165 ni\u017e\u0161iu compliance (t. j. ochotu dodr\u017eiava\u0165 odpor\u00fa\u010dania lek\u00e1ra). Lek\u00e1r sa tu s\u0165a\u017euje na \"nie \u00fapln\u00e9 dodr\u017eiavanie lie\u010dby\".<\/p>\n\n\n\n<p>Rozhodnutie v prospech alternat\u00edvnej medic\u00edny v pr\u00edpade s\u00fa\u010dasnej diagn\u00f3zy rakoviny, ktor\u00e1 sa pod\u013ea vedeck\u00e9ho hodnotenia pova\u017euje za vylie\u010dite\u013en\u00fa, by sa preto mohlo uk\u00e1za\u0165 ako ve\u013ek\u00e1 chyba - a to v ka\u017edej kon\u0161tel\u00e1cii, \u010di u\u017e sa lie\u010di v\u00fdlu\u010dne alebo doplnkovo alternat\u00edvnou medic\u00ednou. Autori \u0161t\u00fadie odpor\u00fa\u010daj\u00fa, aby ka\u017ed\u00fd onkologick\u00fd lek\u00e1r jasne informoval svojich pacientov o t\u00fdchto zisteniach.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<ol class=\"wp-block-list\"><li>Johnson SB, Park HS, Gross CP, Yu JB: Use on Alternative Medicine for Cancer and its Impact on Survival; JNCI J Natl Cancer Inst (2018) 110(1): djx145, doi: 10.1093\/jnci\/djx145&nbsp;<a href=\"https:\/\/euroconsum.eu\/sk\/publication\/alternative-krebstherapien-immer-risiko\/#fnref:1\">\u21a9\ufe0e<\/a><\/li><li>Skyler B. Johnson, MD; Henry S. Park, MD, MPH; Cary P. Gross, MD; et al; Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers; JAMA Oncol. Publikovan\u00e9 online 19. j\u00fala 2018. doi:10.1001\/jamaoncol.2018.2487&nbsp;<a href=\"https:\/\/euroconsum.eu\/sk\/publication\/alternative-krebstherapien-immer-risiko\/#fnref:2\">\u21a9\ufe0e<\/a><\/li><\/ol>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h5 class=\"has-text-align-center wp-block-heading\">Nemeck\u00e9 zdru\u017eenie spotrebite\u013eov<\/h5>\n\n\n\n<h6 class=\"has-text-align-center wp-block-heading\">Na strane d\u00f4kazov, na strane spotrebite\u013eov: Nemeck\u00fd zv\u00e4z spotrebite\u013eov je uzn\u00e1van\u00fdm neziskov\u00fdm zdru\u017een\u00edm na ochranu spotrebite\u013eov.<\/h6>","protected":false},"excerpt":{"rendered":"<p>Diagn\u00f3za rakoviny je v\u017edy udalos\u0165ou, ktor\u00e1 men\u00ed \u017eivot. Okrem v\u0161etk\u00e9ho ostatn\u00e9ho vyvol\u00e1va aj ve\u013ea pochybnost\u00ed a neistoty, pokia\u013e ide o mo\u017enosti lie\u010dby. \u013dudia sa nie v\u017edy riadia radami onkologick\u00fdch odborn\u00edkov, ale uchy\u013euj\u00fa sa k tzv. alternat\u00edvnej medic\u00edne.<\/p>","protected":false},"author":1,"featured_media":1648,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[43],"class_list":["post-1110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-heil-und-arzneimittel-therapien","tag-pseudomedizin"],"_links":{"self":[{"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/posts\/1110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/comments?post=1110"}],"version-history":[{"count":9,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/posts\/1110\/revisions"}],"predecessor-version":[{"id":3553,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/posts\/1110\/revisions\/3553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/media\/1648"}],"wp:attachment":[{"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/media?parent=1110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/categories?post=1110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/euroconsum.eu\/sk\/wp-json\/wp\/v2\/tags?post=1110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}